Physician profile
Garrick Cason
NPI 1124148358
$64,578.03
in general payments reported to CMS, 2019-2025
21 companies · $20K in 2025
The $20K reported for 2025 was more than what 78% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $4,471 · 2021: $2,885 · 2022: $20K · 2023: $4,840 · 2024: $2,911 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Royalty Or License: $3,631 · Food and Beverage: $2,528 · Travel and Lodging: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,626.00 |
| Royalty Or License | $3,631.46 |
| Food and Beverage | $2,527.51 |
| Travel and Lodging | $592.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nexxt Spine LLC | $12,187.50 | 2019-2020 | |
| Providence Medical Technology, INC. | $12,064.59 | 2024-2025 | |
| The Institute of Musculoskeletal Science and Education | $11,703.54 | 2020-2025 | Spira |
| Innovation Technologies INC | $10,502.23 | 2021-2025 | Irrisept |
| Precision Spine, INC. | $9,259.11 | 2021-2024 | |
| Camber Spine Technologies LLC | $5,739.59 | 2020-2023 | |
| Life Spine, INC. | $1,544.20 | 2019-2023 | Arx |
| Spinal Elements, INC. | $677.03 | 2023-2025 | |
| Degen Medical, INC. | $193.99 | 2025 | Alif |
| Surgalign Spine Technologies, INC. | $160.45 | 2021 | |
| Si-Bone, INC. | $150.59 | 2025 | |
| Xtant Medical INC | $133.41 | 2025 | |
| Djo, LLC | $57.18 | 2025 | Cmf |
| Vertex Pharmaceuticals Incorporated | $32.20 | 2025 | |
| Davol INC. | $30.83 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seaspine Orthopedics Corporation | $30.09 | 2021 | |
| Medacta USA, INC. | $28.58 | 2021 | |
| Solventum Corporation | $26.73 | 2025 | Prevena |
| Abbvie INC. | $19.29 | 2023 | Qulipta |
| Boston Scientific Corporation | $18.92 | 2020 | |
| Amgen INC. | $17.98 | 2023 | Prolia, Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garrick Cason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.